SXTC
NASDAQ · Pharmaceuticals
China Sxt Pharmaceuticals In
$1.41
+0.00 (+0.00%)
Open$1.45
Previous Close$1.41
Day High$1.48
Day Low$1.40
52W High$1,046.98
52W Low—
Volume—
Avg Volume26.2K
Market Cap1.43M
P/E Ratio—
EPS$-161.76
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 178.13M | 203.60M | 998.7K |
| Net Income | -338,021,277 | -347,718,767 | 158.4K |
| Profit Margin | -189.8% | -180.3% | 15.9% |
| EBITDA | -264,017,031 | -286,679,825 | 317.7K |
| Free Cash Flow | — | — | 143.5K |
| Rev Growth | -12.5% | -12.5% | +6.7% |
| Debt/Equity | 0.05 | 0.05 | 0.71 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |